Cite

HARVARD Citation

    Fu, L. et al. (n.d.). P0068APABETALONE, A CLINICAL STAGE BET INHIBITOR, REDUCES THE PRO-INFLAMMATORY RESPONSE IN PBMCS FROM FABRY DISEASE PATIENTS ON ERT THERAPY. Nephrology dialysis transplantation. p. . [Online]. 
  
Back to record